Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
4.270
-0.100 (-2.29%)
At close: May 27, 2026, 4:00 PM EDT
4.290
+0.020 (0.47%)
After-hours: May 27, 2026, 7:01 PM EDT
Foghorn Therapeutics Market Cap
Foghorn Therapeutics has a market cap or net worth of $250.71 million as of May 27, 2026. Its market cap has increased by 7.13% in one year.
Market Cap
250.71M
Enterprise Value
109.07M
1-Year Change
7.13%
Ranking
Category
Stock Price
$4.27
Market Cap Chart
Since the IPO on October 23, 2020, Foghorn Therapeutics's market cap has decreased from $565.43M to $250.71M, a decrease of -55.66%. That is a compound annual growth rate of -13.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 256.58M | -15.98% |
| Dec 31, 2025 | 305.38M | 16.38% |
| Dec 31, 2024 | 262.40M | -3.64% |
| Dec 29, 2023 | 272.30M | 2.10% |
| Dec 30, 2022 | 266.70M | -68.56% |
| Dec 31, 2021 | 848.32M | 17.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sol-Gel Technologies | 250.83M |
| Anavex Life Sciences | 249.75M |
| Coherus Oncology | 248.34M |
| Adagene | 247.77M |
| Alector | 245.37M |
| Minerva Neurosciences | 245.06M |
| Orchestra BioMed Holdings | 243.12M |
| Context Therapeutics | 238.89M |